arginine vasopressin has been researched along with Systolic Heart Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burnett, J; Gheorghiade, M; Grinfeld, L; Hauptman, PJ; Konstam, MA; Kostic, D; Krasa, HB; Maggioni, A; Ouyang, J; Swedberg, K; Udelson, JE; Zannad, F; Zimmer, C | 1 |
| Isnard, R | 1 |
1 trial(s) available for arginine vasopressin and Systolic Heart Failure
| Article | Year |
|---|---|
Clinical course of patients with hyponatremia and decompensated systolic heart failure and the effect of vasopressin receptor antagonism with tolvaptan.
Topics: Aged; Analysis of Variance; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Diuretics; Dyspnea; Female; Furosemide; Heart Failure, Systolic; Humans; Hyponatremia; Male; Middle Aged; Proportional Hazards Models; Tolvaptan; Weight Loss | 2013 |
1 other study(ies) available for arginine vasopressin and Systolic Heart Failure
| Article | Year |
|---|---|
[Pathophysiology of heart failure for clinicians].
Topics: Algorithms; Arginine Vasopressin; Blood Pressure; Cardiac Output, Low; Cardiomegaly; Endothelins; Heart; Heart Diseases; Heart Failure; Heart Failure, Diastolic; Heart Failure, Systolic; Humans; Pressoreceptors; Prognosis; Renin-Angiotensin System; Sympathetic Nervous System; Vasoconstrictor Agents; Ventricular Remodeling | 2010 |